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Abstract 
    β-lactam antibiotics, such as penicillin, are the 
biochemical key to preventing bacterial infections. As a 
result of the expression of four classes (A-D) of β-lactamase 
enzymes, bacteria have developed increased resistance to 
antibiotics and continue to pose a daunting public health 
threat. Specifically, class D β-lactamases are characterized 
by a serine nucleophile activated by an atypical 
carboxylated lysine which acts as the general base. Little is 
known about the enzymes' initial recognition of its β-lactam 
substrate and the subsequent mechanistic pathway. Of the 
nearly 160 known Class D β-lactamases that contribute to 
resistance in bacterial infections like Pseudomonas 
aeruginosa, OXA -1 represents a subclass exhibiting 
increased activity against the penicillinase-resistant β-
lactam antibiotic oxacillin. Using a mutant OXA-1 
(Ser67Gly), the structure of the enzyme complexed with the 
hydrolyzed oxacillin product was determined to 1.2 Å 
resolution. This atomic-level structure provides insight into 
the nuances of Class D β-lactamase mechanism. 
 
Research Objectives 
• Obtain crystal structure of OXA-1 β lactamase in a pre-
encounter complex with a penicillin antibiotic in order to 
gain further understanding of the mechanistic pathway of 
OXA-1 β lactamases. 
Conclusions 
• OXA-1 S67G crystal soaked in oxacillin yielded a 1.25 Å 
structure of mechanistic product complex. 
• Gly67 mutant did not prevent (assumed) catalytic 
water from entering pocket and acting as nucleophile 
in place of WT Ser67. 
• β-lactamases are able to adapt to changes(i.e., 
mutations) and carry out directed mechanism, thus one 
reason they are so dangerous in the clinical realm of 
antibiotic resistance. 
• Further purification and crystallization must be done to 
acquire snapshot pathway of OXA-1 β-lactamase and 
antibiotic interaction. 
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Future Research Outlook 
• Continue to pursue a pre-encounter complex involving 
OXA-1 and a β-lactam antibiotic: 
a) crystallize Ser67Gly and soak with antibiotics for 
varying amounts of time, t (i.e., t>5 min., t<5 min.). 
b) crystallize Ser67Ala mutant in hopes of preventing 
catalytic activity of extraneous waters when soaking 
with β-lactam antibiotic. 
• Use the pre-encounter complex as one phase of the 
snapshot series which will help to further define the full 
mechanism of Class D OXA-1 β-lactamase. 
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Structural results of 
OXA-1 S67G 
 with oxacillin 
 Figure I: White mesh representing FO-FC 
electron density map, contoured to 1 σ,  
of hydrolyzed oxacillin in the active site 
of OXA1 S67G.  Figure II:  Product of 
hydrolyzed β-lactam ring stabilized by 
hydrogen bonds (within 3.2Å) with 
surrounding residues and main chain 
carbonyl oxygens and amine hydrogens.   
Figure III:  Alignment of Class D β-
lactamase OXA-1 S67G/oxacillin (blue and 
yellow, respectively) with Class A β-
lactamase CTX-M-9 S70G/benzylpenicillin 
(fuschia and white, respectively) to 
represent conserved nature of key polar 
interactions which stabilize carboxyl 
group of hydrolyzed lactam ring.   
Figure IV:  Overall enzyme-substrate 
interaction following hydrolysis of β-
lactam ring. 
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Figure I: General mechanistic 
highlights of the hydrolysis of β-
lactam antibiotics.  The 
nucleophilicity of Ser67 
motivated the S67G mutation 
with the hypothesis that 
acylation and the resulting 
hydrolysis of the β-lactam ring 
would be prevented.  
Figure II: R-group which 
differentiates oxacillin from 
other penicillins.  
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Figure I: Crystals initially 
obtained using hanging drop 
vapor diffusion of  purified 
3.25 mg/mL protein over 20% 
PEG 8000/100mM HEPES pH 
7.5 
Figure II: Diffraction worthy 
crystals obtained after three 
rounds of microseeding were 
soaked in 33.3 mM oxacillin 
for ~5 minutes and 25% MPD 
followed by flash freezing in 
liquid nitrogen.   
Figure III: 1.25 Å x-ray 
diffraction pattern of OXA-1 
S67G (space group I222) with 
a 97.46% completeness for 
range. 
Figure I. 
Figure II. 
